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Abstract: The purpose of this study was to determine whether subconjunctival administration of enrofloxacin could ameliorate a
herd outbreak of infectious bovine keratoconjunctivitis (IBK) and to compare the efficacy of this regimen with the efficacy of
subconjunctival administration of a combination of penicillin+streptomycin.
The calves were assigned to 1 of 3 groups at the beginning of the study, and were examined 3 times weekly for 4 weeks. Calves in
group 1 (n = 12) were treated with the subconjunctival administration of a combination of penicillin+streptomycin. This treatment
consisted of 3 subconjunctival injections of penicillin+streptomycin every 48 h. Calves in group 2 (n = 13) were treated with
subconjunctival administration of enrofloxacin, which consisted of 3 subconjunctival injections of enrofloxacin (30 mg) every 48 h.
Calves in group 3 (n = 13) were not treated and were used as controls.
Mean time for healing of corneal ulcers and amelioration of clinical signs was significantly less for calves that received enrofloxacin
or penicillin+streptomycin than for the untreated controls.
In conclusion, subconjunctival administration of enrofloxacin appears to be an effective method of reducing the severity of a herd
outbreak of IBK and may be superior to treatment with penicillin+streptomycin.
Key Words: Keratoconjunctivitis, enrofloxacin, calf

‹nfeksiyöz Bovine Keratokonjunktivitisli Buza¤›larda
Farkl› Antibiyotik Tedavilerinin De¤erlendirilmesi
Özet: Bu çal›flmada, ‹nfeksiyöz Bovine Keratokonjunktivitis görülen bir sürüde subkonjunktival uygulanan enrofloksasin’in
iyileflmedeki etkinli¤inin belirlenmesi ve bunun subkonjunktival uygulanan penisilin + streptomisin kombinasyonu etkinli¤i ile
karfl›laflt›r›lmas› amaçland›.
Çal›flma bafllang›c›nda danalar 3 gruba ayr›ld› ve haftada 3 defa olmak üzere 4 hafta boyunca muayene edildi. Grup 1’deki danalar
(n = 12) subkonjunktival penisilin + streptomisin kombinasyonu uygulamas›yla sa¤alt›ld›. Bu tedavi penisilin + streptomisin
kombinasyonu 48 saat arayla 3 defa subkonjunktival uygulanarak gerçeklefltirildi. Grup 2’deki danalar (n = 13) subkonjunktival
enrofloksasin uygulanarak tedavi edildi. Subkonjunktival uygulama 48 saat arayla 3 defa yap›ld›. Group 3’deki danalar (n = 13) ise
tedavi edilmedi ve kontrol grubu olarak kullan›ld›.
Korneal ülserlerin ortalama iyileflme zaman› ve klinik bulgular›n düzelmesi, enrofloksasin ve penisilin + streptomisin kombinasyonu
uygulanan danalarda kontrol grubundakilere göre önemli derecede daha k›sa bulundu.
Sonuç olarak, enrofloksasinin subkonjunktival uygulamas›n›n IBK’ de hastal›¤›n fliddetini azaltmada etkili bir metod oldu¤u ve hasta
hayvanlar›n tedavisinde penisilin streptomisin kombinasyonundan daha etkili oldu¤u görüldü.
Anahtar Sözcükler: Keratokonjunktivitis, enrofloksasin, buza¤›

* E-mail: muratkibar@erciyes.edu.tr
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Introduction
Infectious bovine keratoconjunctivitis (IBK, pinkeye) is
an infectious and contagious ocular disease of cattle
characterized by conjunctivitis and ulcerative keratitis (18). Moraxella bovis causes IBK, an important ocular
disease of cattle, which occurs worldwide. The disease
causes economic losses arising from decreased weight
gain in beef breeds, loss of milk production, short-term
disruption of breeding programs, and treatment costs (36,9-11). Several other infectious agents (i.e. Adenovirus,
Mycoplasma, Branhamella (Neisseria), and Listeria) have
been recovered from the eyes of cattle showing clinical
signs similar to those seen in Moraxella-induced IBK
(1,11-13).
The clinical signs of IBK include excessive lacrimation,
blepharospasm, photophobia, corneal ulceration, opacity,
and occasionally perforation. Circumlimbal corneal
vascularization begins to invade the cornea 4 to 7 days
after ulceration is first seen (3-5,7,10,11).
Pathogenic strains of M. bovis are piliated strains that
initially bind through their pili to receptors on the
surfaces of corneal epithelial cells (1,14-17). M. bovis
causes the most severe disease in young cattle. The
disease is transmitted by direct contact, aerosols, and
fomites. Flies may serve as mechanical vectors of the
bacteria (7,18).
Treatment of IBK is based on antibiotics effective
against moraxella (19,20). Antimicrobial therapy should
be administered subconjunctivally or topically early in the
disease course (3,10,21,22). The practical problem of
treating several individuals within a herd 2 or 3 times
daily has inspired several studies in search of alternate,
more cost-effective therapies, for treating both ulcerative
keratitis and M. bovis in carrier animals (1,19,23,24).
Enrofloxacin, a derivative of quinolone carboxylic acid,
has greater in vitro activity against M. bovis than
norfloxacin. Enrofloxacin has high lipid solubility and low
ionic partitioning, suggesting that it may be extensively
distributed to ocular tissues and may, therefore, be
beneficial in the treatment of IBK. Controlled studies of
the efficacy of subconjunctival administration of
enrofloxacin for treatment of IBK have not, to the best of
our knowledge, been previously reported. Studies have
shown the efficacy of parenterally administered penicillin
for susceptibility of M. bovis (25-30).
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The purpose of this study was to determine whether
subconjunctival administration of enrofloxacin could
ameliorate a herd outbreak of IBK and to compare the
efficacy of this regimen with the efficacy of
subconjunctival administration of a combination of
penicillin+streptomycin.

Materials and Methods
Calves were undergoing a natural epizootic of IBK
when studied. The study included 38 Holstein calves
during the autumn of 2003. The 18 male and 20 female
calves were between 3 and 5 months of age and weighed
between 56 and 102 kg. On the first day of the study,
each calf was examined for clinical signs of IBK. The eyes
of each calf were examined using a portable light while
the calf was restrained in a squeeze chute. All eyes were
numerically scored, ranging from 1 to 6. Scores were
assigned according to the following criteria: (1) normal
eye; (2) 1 or more signs of IBK, without corneal
ulceration; (3) corneal ulcer < 5 mm in diameter; (4)
corneal ulcer ≥ 5 mm in diameter; (5) corneal
perforation; (6) loss of vitreous. In calves that had
photophobia, blepharospasm, or epiphora, the affected
eyes were stained with fluorescein dye (Fluoreszein SE
Thilo, Liba Laboratuarları A.fi.) and irrigated to detect
corneal ulcers on days 0, 7, 14, and 21. On these same 4
days, Schirmer tear test strips (Schirmer Tränentest, Vet.
Eickemeyer) were used to assess the amount of tear
production in affected eyes. In the Schirmer’s tear test I,
the rate of basal and reflex tear production were
measured as the animal forms tears in response to the
sensation of the strip contacting the eye. Fly control was
not used on these calves during the study. The research
began on September 10, 2003; all calves were weaned
the week prior to the study.
The calves were prospectively and randomly assigned
to 1 of 3 groups at the beginning of the study, and were
examined 3 times weekly for 4 weeks. Affected calves in
group 1 (n = 12) were treated with subconjunctival
administration of penicillin+ streptomycin (120,000 U +
1.95 g). This treatment consisted of 3 subconjunctival
injections of penicillin+streptomycin every 48 h. Calves in
group 2 (n = 13) with corneal ulcers were treated with
subconjunctival administration of enrofloxacin. Treatment
consisted of 3 subconjunctival injections of enrofloxacin
(30 mg) every 48 h. Topical local anesthetic
(proparacaine hydrochloride, Alcaine 0.5%, Alcon
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Pharmaceuticals Ltd.) was applied to the eye, and the
antibiotic was injected beneath the bulbar conjunctiva
using separate syringes (0.45 x 10 mm, 26 Gx 9.5 mm).
Calves in group 3 (n = 13) were not treated and were
used as controls. Thereafter, calves were examined 3
times per week for a total of 12 times between
September 10 and November 2, when the IBK epizootic
was considered to be over and most of the eye lesions had
healed. Plastic aprons, obstetric sleeves, and latex
examination gloves were worn when calves were
examined and treated. After examination of each calf,
gloves, sleeves, aprons, and other equipment that was in
contact with ocular secretions were rinsed with 1%
Benzalkonium chloride solution (Zefiran sol., ‹ltafl Ltd.)
and dried, using clean paper towels.
To determine whether calves were infected with M.
bovis, ocular secretions were collected from affected eyes
of calves prior to treatment and once a week thereafter
(days 0, 7, 14, and 21). Ocular secretion specimens were
collected by inserting a separate sterile swab into the
inferior conjunctival fornix, and then directly inoculating
the secretions onto sheep blood agar plates. Inoculated
plates were subsequently streaked for isolation and were
incubated aerobically for 24 h at 37 °C and then
examined for bacterial colonies morphologically
characteristic of M. bovis. Colonies typical of M. bovis
were subcultured and identified, using previously
described morphologic and biochemical criteria
(10,11,16). Minimum inhibitory concentrations of
enrofloxacin were then determined using the agar
dilution method.

A combined healing time for ulcers on calf eyes was
calculated from the day an ulcer was first observed on
either eye to the second consecutive day the calf did not
have corneal ulcers. Clinical scores were reported as the
mean for eyes of each calf on each observation day. Mean
healing times, clinical scores, and Schirmer’s test scores
were analyzed for each time interval by use of the
Kruskal-Wallis test (nonparametric ANOVA). Repeated
measure of mean clinical scores and Schirmer’s test
scores were analyzed for each time interval by use of the
Friedman test (nonparametric repeated measures
ANOVA). When overall differences were found by the
Kruskal-Wallis test (KW) and Friedman test (Fr),
differences between treatment groups were compared by
use of Dunn’s test for multiple comparisons. Samples of
ocular secretions from which M. bovis were recovered
were compared for each weekly interval, as mentioned
above, by use of the chi-square test (χ2). For all tests, a
value of P < 0.05 was considered significant.

Results
On the first day of the study, all calves had one or
more clinical signs of IBK. On day 0, corneal ulcers were
observed in at least one eye of all calves. Corneal ulcers
were detected on the left eye and right eye in 21 (58.3%)
and 15 (41.6%) calves, respectively.
Mean healing time of groups 1 and 2 were not
significantly different, and mean healing time of both
treatment groups was significantly less than that of the
controls (Table 1).

Table 1. Analysis of healing time data.

Groups*

Healing
_ times
X ± SD
Median (Min-Max)

KW test

P

Group 1

20.08 ± 6.36a

13.250

P > 0.05

14.833

P < 0.05

28.857

P < 0.05

17 (14-30)
Group 2

20.16 ± 4.28a
19 (17-30)

Group 3

29.14 ± 1.74b
30 (25-30)

a,b

Difference is statistically significant in groups having different letters in the same column
(P < 0.05).
* Group 1: penicillin+streptomycine combination; group 2: enrofloxacin; group 3: control.
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Mean clinical scores of all calves were not significantly
different on day 0 (Table 2). From day 14 of the study
and continuing until the end of the study, mean clinical
scores of groups 1 and 2 were significantly less than
those of the controls. Significant differences in weekly
clinical scores were not found between groups 1 and 2 at
any of the weekly intervals.
Mean clinical scores of groups 1 and 2 were not
significantly different between day 0 and day 7 (Table 3).
From day 14 and continuing until the end of the study,
mean clinical scores were significantly less than on day 0.
Mean Schirmer’s test scores of all calves were not
significantly different on day 0 (Table 4). On days 7 and
14, mean Schirmer’s test score for group 1 was
significantly less than that of the controls. Significant
differences were not found in weekly Schirmer’s test

scores between groups 1 and 2 at any of the weekly
intervals.
Mean Schirmer’s test scores of all calves were not
significantly different at any of the weekly intervals
(Table 5).
On day 0, M. bovis was isolated from the ocular
secretions of 10, 9, and 10 calves in group 1, group 2,
and group 3, respectively (Table 6). On day 7, M. bovis
was isolated from 3 calves in group 1, 2 calves in group
2, and 10 calves in group 3. On day 14, M. bovis was
isolated from 3 calves in group 1, 1 calf in group 2, and
9 calves in group 3. On day 21, M. bovis was isolated
from 2 calves in group 1, 0 in group 2, and 8 calves in
group 3. Frequency of M. bovis isolation was significantly
lower in calves from groups 1 and 2 compared to the
control group on all observation days after day 0.

Table 2. Analysis of clinical score data.
Groups

Day 0
Med (Min-Max)

Day 7
Med (Min-Max)

Day 14
Med (Min-Max)

Day 21
Med (Min-Max)

Group 1

3.0 (3-5)

2.5 (1-4)

1.5 (1-3)a

1.0 (1-2)a

Group 2

3.0 (2-6)

2.5 (1-5)

1.5 (1-5)a

1.0 (1-5)a

Group 3

3.0 (3-5)

3.0 (3-5)

3.0 (1-5)b

3.0 (1-4)b

KW test

0.467

5.723

13.231

16.535

P > 0.05

P > 0.05

P < 0.05

P < 0.05

P
a,b

Difference is statistically significant in groups having different letters in the same column
(P < 0.05).

Table 3. Analysis of repeated measures of clinical score data for each group.

Groups

Day 0
Med
(Min-Max)

Day 7
Med
(Min-Max)

Day 14
Med
(Min-Max)

Day 21
Med
(Min-Max)

Fr test

P

Group 1

3.0 (3-5)a

2.5 (1-4)ab

1.5 (1-3)b

1.0 (1-2)b

29.969

P < 0.05

Group 2

a

3.0 (2-6)

ab

2.5 (1-5)

b

1.5 (1-5)

b

1.0 (1-5)

29.292

P < 0.05

Group 3

3.0 (3-5)

3.0 (3-5)

3.0 (1-5)

3.0 (1-4)

4.385

P > 0.05

a,b

Difference is statistically significant in groups having different letters in the same horizontal line
(P < 0.05).
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Table 4. Analysis of Schirmer’s test score data.

Groups

Day 0
_
X ± SD
Med (Min-Max)

Day 7
_
X ± SD
Med (Min-Max)

Day 14
_
X ± SD
Med (Min-Max)

Day 21
_
X ± SD
Med (Min-Max)

Group 1

26.75 ± 5.83

27.58 ± 5.33a

26.41 ± 5.74a

27.91 ± 3.42

25.5 (20-35)

27.5 (17-35)

26.5 (18-35)

28.5 (22-34)

Group 2

Group 3

29.92 ± 5.38

30.00 ± 4.55

31.0 (21-35)

30.5 (20-35)
b

ab

27.75 ± 5.19

29.16 ± 3.85

27.5 (20-35)

28.5 (23-34)

b

31.58 ± 2.75

32.50 ± 1.78

31.58 ± 2.11

30.08 ± 1.31

31.5 (27-35)

32.0 (30-35)

31.0 (29-35)

30.0 (27-32)

4.228

6.362

7.561

3.817

P > 0.05

P < 0.05

P < 0.05

P > 0.05

KW Test
P

ab

a,b

: Difference is statistically significant in groups having different letters in the same column
(P < 0.05).

Table 5. Analysis of repeated measures of Schirmer’s test score data for each group.

Groups

Day 0
Median
(Min-Max)

Day 7
Median
(Min-Max)

Day 14
Median
(Min-Max)

Day 21
Median
(Min-Max)

Fr test

P

Group 1

25.5

27.5

26.5

28.5

0.868

P > 0.05

(20-35)

(17-35)

(18-35)

(22-34)

31.0

30.5

27.5

28.5

4.205

P > 0.05

(21-35)

(20-35)

(20-35)

(22-34)

31.5

32.0

31.0

31.0

4.330

P > 0.05

(27-35)

(30-35)

(29-35)

(29-35)

Group 2

Group 3

Table 6. Isolation of Moraxella bovis from ocular secretions.
Day 0

Day 7

Day 14

Day 21

Groups
n

(%)

n

(%)

n

(%)

n

(%)

Group 1

10

(83.3)

3*

(25.0)

3*

(25.5)

2*

(16.7)

Group 2

9

(75.0)

2*

(16.7)

1*

(8.3)

0*

(0)

Group 3

10

(83.3)

10

(83.3)

9

(75.0)

8

(66.7)

* Significantly different from control group (P < 0.05).
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Discussion
In this study, enrofloxacin and a combination of
penicillin+streptomycin were both found to be effective in
the treatment of naturally induced IBK, as healing times
of corneal ulcers were significantly shorter in the
treatment groups compared to the control group.
Subconjunctival administration of enrofloxacin and
penicillin+streptomycin also resulted in significant
reductions in clinical score, Schirmer’s tear test score, and
the rate of M. bovis isolation from ocular secretions.
Clinical signs of infection and corneal lesions observed
in the study calves were similar to those of clinical cases
(4,5,7,13,29). Variability in the severity of ocular lesions
may have resulted from immunologic and genetic factors.
A previous study of calves with IBK that were treated
with procaine penicillin G suggested that corneal
epithelium may regenerate at a constant rate following
clearance of an M. bovis infection (28,30), and,
therefore, elimination of M. bovis infection is considered
important for achieving resolution of IBK. Enrofloxacin
and procaine penicillin G have both been shown to
eliminate M. bovis (14,29); however, the comparative
efficacy of these 2 antibiotics remains unknown.

Enrofloxacin may be an effective therapeutic alternative
to penicillin+streptomycin combination for the treatment
of IBK in the event that M. bovis develops penicillin
resistance.
In the present study, significant differences in healing
times, clinical scores, and Schirmer’s Test scores were
probably attributable to the effectiveness of the antibiotic
treatment to eliminate M. bovis infection. The healing
rate of corneal ulcers is directly and linearly correlated to
maximal ulcer size, providing the bacterial infection has
been eliminated (22,25). Although healing time was
similar for calves treated with enrofloxacin and
penicillin+streptomycin, calves treated with enrofloxacin
had a lower prevalence of IBK compared to the calves
treated with the penicillin+streptomycin combination.
Initial treatment of calves with enrofloxacin was effective
in eliminating most ocular infections, as evidenced by the
lower frequency of M. bovis isolation in this group.
In conclusion, subconjunctival administration of
enrofloxacin appears to be an effective method of
reducing the severity of a herd outbreak of IBK and may
be superior to treatment of affected animals with
penicillin+streptomycin.
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